Headline Roundup • October 23rd, 2020
Antiviral Drug Remdesivir Approved as COVID-19 Treatment by FDA
Summary from the AllSides News Team
Featured Coverage of this Story
Newsweek
The Food and Drug Administration (FDA) on Thursday approved remdesivir for the treatment of hospitalized COVID-19 patients.
The antiviral treatment, which is made by Gilead Sciences and sold as Veklury, was used to treat President Donald Trump after he contracted the virus earlier this month.
Remdesivir previously received emergency use authorization from the FDA in May for patients with severe cases of COVID-19. The agency later expanded its emergency use authorization in August to include patients who were hospitalized as a result of their COVID-19 infections.
The Food and Drug Administration granted approval of remdesivir, an antiviral drug from Gilead Sciences and a treatment for COVID-19.
The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients, Gilead said. It is the first coronavirus disease treatment to receive FDA approval.
“The approval of Veklury marks an important milestone in efforts to help address the pandemic by offering an effective treatment that helps patients recover faster and, in turn, helps preserve scarce healthcare resources,” said Dr. Barry Zingman, a professor at the Albert Einstein...
The Food and Drug Administration (FDA) on Thursday approved the antiviral drug remdesivir as a treatment for patients with COVID-19 who require hospitalization.
Given through an IV, remdesivir works to stop replication of SARS-CoV-2, the virus that causes COVID-19, according to the drug's manufacturer, California-based Gilead Sciences, Inc. Previously authorized by the FDA for emergency use to treat COVID-19, the drug is now the first and only approved COVID-19 treatment in the United States, Gilead said in a release.
“Since the beginning of the COVID-19 pandemic, Gilead has worked relentlessly...
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
ICE Detains Conservative Influencer Milo Yiannopoulos in Louisiana
August 28th, 2026
Headline Roundup
USAID Report Claims Over 100 UNRWA Employees Participated in October 7 Attacks
August 28th, 2026
Blog
Will Data Centers Create Blackouts? Examining Media Bias and Misinformation on The Tucker Carlson Show
Julie Mastrine
August 28th, 2026
